Motif Bio plc – AIM Equity Fundraising

Thursday 25 June 2015

Marriott Harrison LLP corporate partner Simon Charles has advised Northland Capital Partners Limited and Zeus Capital Limited in their role as brokers on a £22m AIM equity fundraising for AIM listed drug development company Motif Bio plc.

Simon Charles
Partner
MH Corporate